Lung Cancer
Conditions
Keywords
Data collection, lung cancer
Brief summary
Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.
Interventions
One optional veinous blood sampling (24 ML) between the first diagnostic annoucement and before the first treatment for lung cancer
to collect data not reported in the patient's medical file, such as passive smoking, family history of cancer, and attempts to quit smoking.
Sponsors
Study design
Intervention model description
One questionnaire between diagnostic annoucement and first line treatement One 6 months later One before second line treatment One 6 months later after second line treatment Optionnal Veinous Blood Sample (28 mL) between the diagnostic annoucement and the first line of treatment
Eligibility
Inclusion criteria
* Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma… * Diagnosis can be done: * By cytology or pathologic assessment * Or by multidisciplinary team meeting decision: * Irradiation without morpho-metabolic sampling * Treatment without sampling based on non-invasive molecular data
Exclusion criteria
\- Refusal to participate For optional blood sampling : * \< 30 kg for blood collection * No blood sampling schedule for care
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants registered in the lung cancer database | 20 years | cohort open to recruitment during 10 years with 10 years of patients follow-up |
Countries
France